Healthlead Public Valuation
| HL Stock | 9.90 0.85 9.39% |
At this time, the firm appears to be undervalued. Healthlead Public retains a regular Real Value of USD10.35 per share. The prevalent price of the firm is USD9.9. Our model calculates the value of Healthlead Public from evaluating the firm fundamentals such as return on equity of 0.2, and Return On Asset of 0.1 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Healthlead Public's price fluctuation is not too volatile at this time. Calculation of the real value of Healthlead Public is based on 3 months time horizon. Increasing Healthlead Public's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Healthlead Public's intrinsic value may or may not be the same as its current market price of 9.90, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.9 | Real 10.35 | Hype 9.9 | Naive 9.92 |
The intrinsic value of Healthlead Public's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Healthlead Public's stock price.
Estimating the potential upside or downside of Healthlead Public helps investors to forecast how Healthlead stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Healthlead Public more accurately as focusing exclusively on Healthlead Public's fundamentals will not take into account other important factors: Healthlead Public Total Value Analysis
Healthlead Public is currently forecasted to have takeover price of 6.02 B with market capitalization of 6.77 B, debt of 307.98 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Healthlead Public fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.02 B | 6.77 B | 307.98 K |
Healthlead Public Investor Information
About 77.0% of the company shares are held by company insiders. The company last dividend was issued on the 11th of March 2022. Based on the measurements of operating efficiency obtained from Healthlead Public's historical financial statements, Healthlead Public is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Healthlead Public Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Healthlead Public has an asset utilization ratio of 107.19 percent. This suggests that the Company is making USD1.07 for each dollar of assets. An increasing asset utilization means that Healthlead Public is more efficient with each dollar of assets it utilizes for everyday operations.Healthlead Public Ownership Allocation
Healthlead Public has a total of 272 Million outstanding shares. Healthlead Public retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.13 (percent) of Healthlead Public outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Healthlead Public Profitability Analysis
The company reported the revenue of 1.2 B. Net Income was 79.66 M with profit before overhead, payroll, taxes, and interest of 293.95 M.About Healthlead Public Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Healthlead Public. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Healthlead Public based exclusively on its fundamental and basic technical indicators. By analyzing Healthlead Public's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Healthlead Public's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Healthlead Public. We calculate exposure to Healthlead Public's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Healthlead Public's related companies.8 Steps to conduct Healthlead Public's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Healthlead Public's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Healthlead Public's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Healthlead Public's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Healthlead Public's revenue streams: Identify Healthlead Public's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Healthlead Public's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Healthlead Public's growth potential: Evaluate Healthlead Public's management, business model, and growth potential.
- Determine Healthlead Public's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Healthlead Public's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Healthlead Stock
Healthlead Public financial ratios help investors to determine whether Healthlead Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthlead with respect to the benefits of owning Healthlead Public security.